Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_assertion description "[Experience with these agents in patients with refractory anemia with excess blasts in transformation (reclassified by the World Health Organization as AML) was also reported in the clinical trials submitted to the FDA for approval of azacitidine for MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_assertion evidence source_evidence_literature NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_assertion SIO_000772 16341239 NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_assertion wasDerivedFrom befree-20140225 NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_assertion wasGeneratedBy ECO_0000203 NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.
- befree-20140225 importedOn "2014-02-25" NP449051.RAkDAIfl_dvroywY3SX5WWF0Dmig7uyO--5VLU3kYjuas130_provenance.